Drugs / LORACARBEF ANHYDROUS
LORACARBEF ANHYDROUS
also known as
Anhydrous loracarbef · Lorabid · Loracarbef · Loracarbef monohydrate · Lorbef · LY-163892 · LY-163892 MONOHYDRATE
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | LORABID | — | 1996-11-13 | fda.gov ↗ |
| Approved | US (FDA) | LORABID | — | 1991-12-31 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LORACARBEF ANHYDROUS | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Known as | Anhydrous loracarbef | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Known as | Lorabid | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Known as | Loracarbef | “Loracarbef” NCT02099240 ↗ |
| Known as | Loracarbef monohydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Known as | Lorbef | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Known as | LY-163892 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Known as | LY-163892 MONOHYDRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1013 ↗ |
| Modality | Small molecule | — CHEMBL1013 ↗ |